Format

Send to

Choose Destination
Bioorg Med Chem. 2010 Jul 15;18(14):5071-80. doi: 10.1016/j.bmc.2010.05.071. Epub 2010 Jun 2.

Morphinans and isoquinolines: acetylcholinesterase inhibition, pharmacophore modeling, and interaction with opioid receptors.

Author information

1
Department of Pharmaceutical Chemistry, Institute of Pharmacy, University of Innsbruck and Center for Molecular Biosciences Innsbruck-CMBI, Innrain 52a/c, A-6020 Innsbruck, Austria.

Abstract

Following indications from pharmacophore-based virtual screening of natural product databases, morphinan and isoquinoline compounds were tested in vitro for acetylcholinesterase (AChE) inhibition. After the first screen, active and inactive compounds were used to build a ligand-based pharmacophore model in order to prioritize compounds for biological testing. Among the virtual hits tested, the enrichment of actives was significantly higher than in a random selection of test compounds. The most active compounds were biochemically tested for their activity on mu, delta, and kappa opioid receptors.

PMID:
20580236
DOI:
10.1016/j.bmc.2010.05.071
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center